Details for New Drug Application (NDA): 040797
✉ Email this page to a colleague
The generic ingredient in MEPROBAMATE is aspirin; meprobamate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; meprobamate profile page.
Summary for 040797
Tradename: | MEPROBAMATE |
Applicant: | Invagen Pharms |
Ingredient: | meprobamate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 040797
Suppliers and Packaging for NDA: 040797
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MEPROBAMATE | meprobamate | TABLET;ORAL | 040797 | ANDA | Cipla USA Inc. | 69097-974 | 69097-974-07 | 100 TABLET in 1 BOTTLE (69097-974-07) |
MEPROBAMATE | meprobamate | TABLET;ORAL | 040797 | ANDA | Cipla USA Inc. | 69097-975 | 69097-975-07 | 100 TABLET in 1 BOTTLE (69097-975-07) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Feb 27, 2008 | TE: | AA | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Feb 27, 2008 | TE: | AA | RLD: | No |
Complete Access Available with Subscription